查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1828873

非小細胞肺癌 (NSCLC) 市場分析與至2034年的預測：按類型、產品、技術、應用、最終用戶、階段、設備、解決方案和流程

Non-Small Cell Lung Cancer (NSCLC) Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Stage, Device, Solutions, Process
出版日期: | 出版商: Global Insight Services | 英文 385 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

非小細胞肺癌（NSCLC）市場預計將從2024年的195億美元擴大到2034年的616億美元，年複合成長率約為 12.2%。非小細胞肺癌（NSCLC）市場包括針對最常見的肺癌類型 NSCLC 的治療解決方案的開發、生產和分銷。該市場的特點是創新治療方法，例如標靶治療和免疫療法，目的是改善患者預後。在發病率上升和精準醫療進步的推動下，由於對研究和臨床試驗的大量投資，市場有望實現成長。主要趨勢包括個人化醫療方法、聯合治療以及整合生物標記以提高治療效果。

非小細胞肺癌（NSCLC）市場正經歷強勁成長，主要得益於標靶治療和免疫療法的進步。目前，標靶治療領域以 EGFR 抑制劑和 ALK 抑制劑為主導，由於它們對特定基因突變的有效性，它們表現最佳。免疫療法，尤其是 PD-1 和 PD-L1 抑制劑，表現第二佳，反映出它們擴大被用作一線治療。聯合治療動力強勁，提高了療效並改善了患者預後。雖然化療衰落，但它仍然佔有重要地位，尤其是與其他治療方法合併使用時。在基因組分析和生物標記識別進步的支持下，個人化醫療已成為關鍵趨勢。這一趨勢推動伴隨診斷的創新和投資。在病患偏好和成本效益的推動下，門診病人也出現了轉變。持續的研究和開發工作預計將帶來新的治療選擇，進一步推動市場成長。

細分市場
種類 腺癌、鱗狀細胞癌、大細胞癌
產品 標靶治療、免疫治療、化療和放射線治療
技術 生物標記檢測、基因檢測、診斷影像技術、奈米技術
用途 一線治療、第二線治療、維持治療、輔助治療、新輔助治療
最終用戶 醫院、癌症研究機構、專科診所、製藥公司
階段 第一階段、第二階段、第三階段、第四階段
裝置 切片檢查設備、診斷影像設備、放射治療設備
解決方案 病患管理、臨床試驗和藥物開發
流程 藥物發現、臨床開發、監管核准和上市

市場概述

非小細胞肺癌（NSCLC）市場正經歷動態變化，創新的定價策略和新型治療藥物的引進導致市場佔有率大幅波動。該市場的特點是不斷推出目的是滿足未滿足醫療需求和改善患者預後的新型治療藥物。這些新進業者的競爭性定價重塑市場動態，並促進更廣泛的可及性和應用。受當地法規結構和醫療政策的影響，各主要地區的定價趨勢各不相同。隨著製藥公司繼續致力於研發以保持競爭力，市場將進一步發展。競爭性基準基準化分析突顯了老牌大型製藥企業和新興生物技術公司在 NSCLC 市場中的激烈競爭。監管影響發揮關鍵作用，嚴格的核准流程影響新產品的推出速度。北美和歐洲在監管領域佔據主導地位，為安全性和有效性設定了高標準。雖然這些地區在市場佔有率方面也處於領先地位，但由於對醫療基礎設施的投資增加和患者人數的不斷成長，亞太地區正逐漸成為關鍵參與者。策略聯盟和合併進一步塑造了競爭格局。隨著企業尋求加強其市場地位和擴大產品系列，此類聯盟和合併變得越來越普遍。

主要趨勢和促進因素

在標靶治療和免疫治療的推動下，非小細胞肺癌（NSCLC）市場經歷變革性成長。主要趨勢包括個人化醫療方法的開發、治療效果和患者預後的改善。人工智慧在診斷領域的整合加速早期發現和精準治療計劃，推動市場擴張。生物標記主導療法的興起也是一個關鍵趨勢，它使得更個人化和有效的治療方法成為可能。不斷增加的研發投入刺激技術創新並創造新的治療選擇。 NSCLC 盛行率的上升，加上人口老化，大大推動了對先進治療方案的需求。此外，監管支持和突破性療法的快速核准流程促進其快速進入市場。醫療基礎設施發達、肺癌意識日益增強的新興市場提供了充足的商機。致力於策略夥伴關係和擴展產品平臺的公司能夠充分利用這一充滿活力的市場環境。

限制與挑戰：

NSCLC 市場面臨幾個重大的限制和挑戰。一個關鍵挑戰是標靶治療和免疫療法的成本高昂，限制了低收入地區患者的治療機會。這些先進的療法通常價格過高，阻礙了其廣泛採用並加劇了醫療保健的不公平性。此外，NSCLC 複雜的基因圖譜需要個人化的治療方法，並使治療通訊協定的標準化變得複雜。這種複雜性也增加了醫療保健提供者的負擔，使他們需要及時了解最新發展並相應地調整治療方案。另一個挑戰是與新治療方法的核准相關的監管障礙，這可能會延遲市場進入並增加開發成本。此外，與 NSCLC 治療相關的副作用可能很嚴重，影響患者的生活品質和治療順從性。最後，某些地區無法獲得全面的基因組檢測，這阻礙了精準醫療的有效實施並限制了最佳治療效果。

主要企業

BeiGene、Innovent Biologics、Zai Lab、Hutchmed、Array BioPharma、Blueprint Medicines、Mirati Therapeutics、Turning Point Therapeutics、Iovance Biotherapeutics、MacroGenics、Daiichi Sankyo、Eisai、Sumitomo Dainippon Pharma、Chugai Pharmaceutical、 Kyowa Kirin

目錄

第1章 非小細胞肺癌（NSCLC）市場概述

  • 分析目的
  • 非小細胞肺癌（NSCLC）市場定義和範圍
  • 報告限制
  • 分析期和貨幣
  • 分析方法

第2章 執行摘要

第3章 關鍵市場考察因素

第4章 非小細胞肺癌（NSCLC）市場展望

  • 非小細胞肺癌（NSCLC）市場區隔
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • ANSOFF矩陣

第5章 非小細胞肺癌（NSCLC）市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭分析
  • 近期動態

第6章 非小細胞肺癌（NSCLC）市場規模

  • 非小細胞肺癌（NSCLC）市場規模：依金額
  • 非小細胞肺癌（NSCLC）市場規模：依數量

第7章 非小細胞肺癌（NSCLC）市場：依類型

  • 市場概況
  • 腺癌
  • 鱗狀細胞癌
  • 大細胞癌
  • 其他

第8章 非小細胞肺癌（NSCLC）市場（依產品）

  • 市場概況
  • 標靶治療藥物
  • 免疫療法
  • 化療藥物
  • 放射線治療
  • 其他

第9章 非小細胞肺癌（NSCLC）市場（依技術）

  • 市場概況
  • 生物標記檢測
  • 基因檢測
  • 診斷影像技術
  • 奈米科技
  • 其他

第10章 非小細胞肺癌（NSCLC）市場（依應用）

  • 市場概況
  • 一線治療
  • 二線治療
  • 維持治療
  • 輔助治療
  • 新輔助治療
  • 其他

第11章 非小細胞肺癌（NSCLC）市場（依最終用戶）

  • 市場概況
  • 醫院
  • 癌症研究所
  • 專科診所
  • 製藥公司
  • 其他

第12章 非小細胞肺癌（NSCLC）市場（依階段）

  • 市場概況
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段
  • 其他

第13章 非小細胞肺癌（NSCLC）市場（依設備）

  • 市場概況
  • 切片檢查裝置
  • 診斷影像設備
  • 放射治療設備
  • 其他

第14章 非小細胞肺癌（NSCLC）市場（依解決方案）

  • 市場概況
  • 病人管理
  • 臨床試驗
  • 藥物開發
  • 其他

第15章 非小細胞肺癌（NSCLC）市場（依流程）

  • 市場概況
  • 藥物研發
  • 臨床開發
  • 藥品核准
  • 上市
  • 其他

第16章 非小細胞肺癌（NSCLC）市場（依地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第17章 競爭格局

  • 概述
  • 市場佔有率分析
  • 主要企業定位
  • 競爭領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第18章 公司簡介

  • BeiGene
  • Innovent Biologics
  • Zai Lab
  • Hutchmed
  • Array BioPharma
  • Blueprint Medicines
  • Mirati Therapeutics
  • Turning Point Therapeutics
  • Iovance Biotherapeutics
  • MacroGenics
  • Daiichi Sankyo
  • Eisai
  • Sumitomo Dainippon Pharma
  • Chugai Pharmaceutical
  • Kyowa Kirin
簡介目錄
Product Code: GIS34093

Non-Small Cell Lung Cancer (NSCLC) Market is anticipated to expand from $19.5 billion in 2024 to $61.6 billion by 2034, growing at a CAGR of approximately 12.2%. The Non-Small Cell Lung Cancer (NSCLC) Market encompasses the development, production, and distribution of therapeutic solutions targeting NSCLC, the most prevalent form of lung cancer. This market is characterized by innovative treatments, including targeted therapies and immunotherapies, aimed at improving patient outcomes. Driven by rising incidence rates and advancements in precision medicine, the market is poised for growth, with significant investment in research and clinical trials. Key trends include personalized medicine approaches, combination therapies, and the integration of biomarkers for enhanced treatment efficacy.

The Non-Small Cell Lung Cancer (NSCLC) Market is experiencing robust growth, primarily driven by advancements in targeted therapies and immunotherapies. The targeted therapy segment is currently the top-performing, with EGFR inhibitors and ALK inhibitors leading due to their efficacy in specific genetic mutations. Immunotherapy, particularly PD-1 and PD-L1 inhibitors, is the second highest-performing segment, reflecting its increasing adoption as a first-line treatment. Combination therapies are gaining momentum, offering enhanced efficacy and improved patient outcomes. The chemotherapy segment, while declining, remains relevant, especially in combination with other modalities. Personalized medicine is emerging as a key trend, supported by advancements in genomic profiling and biomarker identification. This trend is driving innovation and investment in companion diagnostics. The market is also witnessing a shift towards outpatient settings, influenced by patient preference and cost efficiency. Continuous research and development efforts are expected to yield novel treatment options, further propelling market growth.

Market Segmentation
TypeAdenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma
ProductTargeted Therapy Drugs, Immunotherapy Drugs, Chemotherapy Drugs, Radiotherapy
TechnologyBiomarker Testing, Genetic Testing, Imaging Technologies, Nanotechnology
ApplicationFirst-Line Treatment, Second-Line Treatment, Maintenance Therapy, Adjuvant Therapy, Neoadjuvant Therapy
End UserHospitals, Cancer Research Institutes, Specialty Clinics, Pharmaceutical Companies
StageStage I, Stage II, Stage III, Stage IV
DeviceBiopsy Devices, Diagnostic Imaging Systems, Radiotherapy Equipment
SolutionsPatient Management, Clinical Trials, Drug Development
ProcessDrug Discovery, Clinical Development, Regulatory Approval, Commercialization

Market Snapshot:

The Non-Small Cell Lung Cancer (NSCLC) market is witnessing dynamic changes, with significant shifts in market share driven by innovative pricing strategies and the introduction of new therapeutic products. The landscape is characterized by the launch of novel treatments that aim to address unmet medical needs, thereby enhancing patient outcomes. The competitive pricing of these new entrants is reshaping the market dynamics, encouraging broader accessibility and adoption. Key regions are experiencing varied pricing trends, influenced by local regulatory frameworks and healthcare policies. The market is poised for further evolution as pharmaceutical companies continue to focus on research and development to maintain a competitive edge. In terms of competition benchmarking, the NSCLC market is marked by intense rivalry among established pharmaceutical giants and emerging biotech firms. Regulatory influences play a pivotal role, with stringent approval processes impacting the pace of new product introductions. North America and Europe dominate the regulatory landscape, setting high standards for safety and efficacy. These regions also lead in terms of market share, yet Asia-Pacific is emerging as a significant player due to increased investment in healthcare infrastructure and a growing patient population. The competitive landscape is further shaped by strategic alliances and mergers, which are becoming increasingly common as companies seek to enhance their market position and expand their product portfolios.

Geographical Overview:

The NSCLC market is witnessing robust growth across diverse regions, each exhibiting unique characteristics. North America remains a dominant force, driven by advanced healthcare infrastructure and significant R&D investments. The region's focus on innovative therapies and precision medicine is fostering market expansion. Europe follows closely, with strong governmental support and a rising prevalence of lung cancer contributing to market dynamics. The Asia Pacific region is experiencing rapid growth, propelled by increased healthcare spending and a burgeoning population. Countries like China and India are emerging as key players, with large patient pools and improving healthcare access. Latin America and the Middle East & Africa are also showing promising growth, albeit at a slower pace. In Latin America, Brazil and Mexico are leading the charge with enhanced healthcare initiatives. The Middle East & Africa are recognizing the need for improved cancer care, spurring investments in healthcare infrastructure and treatment options.

Key Trends and Drivers:

The Non-Small Cell Lung Cancer (NSCLC) market is experiencing transformative growth driven by advancements in targeted therapies and immunotherapies. Key trends include the development of personalized medicine approaches, enhancing treatment efficacy and patient outcomes. The integration of artificial intelligence in diagnostics is accelerating early detection and precision treatment planning, boosting market expansion. The rise of biomarker-driven therapies is another pivotal trend, allowing for more tailored and effective treatment regimens. Increasing investment in research and development is fostering innovation, leading to novel therapeutic options. The growing prevalence of NSCLC, coupled with an aging population, is significantly driving demand for advanced treatment solutions. Moreover, regulatory support and expedited approval processes for breakthrough therapies are facilitating faster market entry. Opportunities abound in emerging markets where healthcare infrastructure is improving, and awareness of lung cancer is rising. Companies focusing on strategic collaborations and expanding their product pipelines are well-positioned to capitalize on these dynamic market conditions.

Restraints and Challenges:

The NSCLC market encounters several significant restraints and challenges. One primary challenge is the high cost of targeted therapies and immunotherapies, which limits access for patients in low-income regions. These advanced treatments often come with prohibitive pricing, deterring widespread adoption and exacerbating healthcare inequalities. Moreover, the complexity of NSCLC's genetic landscape necessitates personalized treatment approaches, complicating the standardization of care protocols. This complexity also increases the burden on healthcare providers to stay updated with the latest developments and tailor treatments accordingly. Another challenge is the regulatory hurdles associated with the approval of new therapies, which can delay market entry and increase development costs. Additionally, the side effects associated with NSCLC treatments can be severe, impacting patient quality of life and adherence to therapy. Finally, the limited availability of comprehensive genomic testing in certain regions hampers the ability to implement precision medicine effectively, constraining optimal treatment outcomes.

Key Players:

BeiGene, Innovent Biologics, Zai Lab, Hutchmed, Array BioPharma, Blueprint Medicines, Mirati Therapeutics, Turning Point Therapeutics, Iovance Biotherapeutics, MacroGenics, Daiichi Sankyo, Eisai, Sumitomo Dainippon Pharma, Chugai Pharmaceutical, Kyowa Kirin

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Non-Small Cell Lung Cancer (NSCLC) Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Non-Small Cell Lung Cancer (NSCLC) Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Stage
  • 2.9 Key Highlights of the Market, by Device
  • 2.10 Key Highlights of the Market, by Solutions
  • 2.11 Key Highlights of the Market, by Process
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Stage
  • 3.8 Market Attractiveness Analysis, by Device
  • 3.9 Market Attractiveness Analysis, by Solutions
  • 3.10 Market Attractiveness Analysis, by Process
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Non-Small Cell Lung Cancer (NSCLC) Market Outlook

  • 4.1 Non-Small Cell Lung Cancer (NSCLC) Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Non-Small Cell Lung Cancer (NSCLC) Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Non-Small Cell Lung Cancer (NSCLC) Market Size

  • 6.1 Non-Small Cell Lung Cancer (NSCLC) Market Size, by Value
  • 6.2 Non-Small Cell Lung Cancer (NSCLC) Market Size, by Volume

7: Non-Small Cell Lung Cancer (NSCLC) Market, by Type

  • 7.1 Market Overview
  • 7.2 Adenocarcinoma
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Squamous Cell Carcinoma
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Large Cell Carcinoma
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Non-Small Cell Lung Cancer (NSCLC) Market, by Product

  • 8.1 Market Overview
  • 8.2 Targeted Therapy Drugs
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Immunotherapy Drugs
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Chemotherapy Drugs
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Radiotherapy
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Non-Small Cell Lung Cancer (NSCLC) Market, by Technology

  • 9.1 Market Overview
  • 9.2 Biomarker Testing
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Genetic Testing
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Imaging Technologies
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Nanotechnology
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Non-Small Cell Lung Cancer (NSCLC) Market, by Application

  • 10.1 Market Overview
  • 10.2 First-Line Treatment
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Second-Line Treatment
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Maintenance Therapy
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Adjuvant Therapy
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Neoadjuvant Therapy
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Non-Small Cell Lung Cancer (NSCLC) Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Cancer Research Institutes
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Specialty Clinics
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Pharmaceutical Companies
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Non-Small Cell Lung Cancer (NSCLC) Market, by Stage

  • 12.1 Market Overview
  • 12.2 Stage I
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Stage II
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Stage III
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Stage IV
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: Non-Small Cell Lung Cancer (NSCLC) Market, by Device

  • 13.1 Market Overview
  • 13.2 Biopsy Devices
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Diagnostic Imaging Systems
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Radiotherapy Equipment
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Non-Small Cell Lung Cancer (NSCLC) Market, by Solutions

  • 14.1 Market Overview
  • 14.2 Patient Management
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Clinical Trials
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Drug Development
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Non-Small Cell Lung Cancer (NSCLC) Market, by Process

  • 15.1 Market Overview
  • 15.2 Drug Discovery
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Clinical Development
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Regulatory Approval
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Commercialization
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region
  • 15.6 Others
    • 15.6.1 Key Market Trends & Opportunity Analysis
    • 15.6.2 Market Size and Forecast, by Region

16: Non-Small Cell Lung Cancer (NSCLC) Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Technology
    • 16.2.5 North America Market Size and Forecast, by Application
    • 16.2.6 North America Market Size and Forecast, by End User
    • 16.2.7 North America Market Size and Forecast, by Stage
    • 16.2.8 North America Market Size and Forecast, by Device
    • 16.2.9 North America Market Size and Forecast, by Solutions
    • 16.2.10 North America Market Size and Forecast, by Process
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Technology
      • 16.2.9.4 United States Market Size and Forecast, by Application
      • 16.2.9.5 United States Market Size and Forecast, by End User
      • 16.2.9.6 United States Market Size and Forecast, by Stage
      • 16.2.9.7 United States Market Size and Forecast, by Device
      • 16.2.9.8 United States Market Size and Forecast, by Solutions
      • 16.2.9.9 United States Market Size and Forecast, by Process
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Technology
      • 16.2.10.4 Canada Market Size and Forecast, by Application
      • 16.2.10.5 Canada Market Size and Forecast, by End User
      • 16.2.10.6 Canada Market Size and Forecast, by Stage
      • 16.2.10.7 Canada Market Size and Forecast, by Device
      • 16.2.10.8 Canada Market Size and Forecast, by Solutions
      • 16.2.10.9 Canada Market Size and Forecast, by Process
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Technology
    • 16.3.5 Europe Market Size and Forecast, by Application
    • 16.3.6 Europe Market Size and Forecast, by End User
    • 16.3.7 Europe Market Size and Forecast, by Stage
    • 16.3.8 Europe Market Size and Forecast, by Device
    • 16.3.9 Europe Market Size and Forecast, by Solutions
    • 16.3.10 Europe Market Size and Forecast, by Process
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Solutions
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Technology
      • 16.3.10.4 Germany Market Size and Forecast, by Application
      • 16.3.10.5 Germany Market Size and Forecast, by End User
      • 16.3.10.6 Germany Market Size and Forecast, by Stage
      • 16.3.10.7 Germany Market Size and Forecast, by Device
      • 16.3.10.8 Germany Market Size and Forecast, by Solutions
      • 16.3.10.9 Germany Market Size and Forecast, by Process
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Technology
      • 16.3.11.4 France Market Size and Forecast, by Application
      • 16.3.11.5 France Market Size and Forecast, by End User
      • 16.3.11.6 France Market Size and Forecast, by Stage
      • 16.3.11.7 France Market Size and Forecast, by Device
      • 16.3.11.8 France Market Size and Forecast, by Solutions
      • 16.3.11.9 France Market Size and Forecast, by Process
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Technology
      • 16.3.12.4 Spain Market Size and Forecast, by Application
      • 16.3.12.5 Spain Market Size and Forecast, by End User
      • 16.3.12.6 Spain Market Size and Forecast, by Stage
      • 16.3.12.7 Spain Market Size and Forecast, by Device
      • 16.3.12.8 Spain Market Size and Forecast, by Solutions
      • 16.3.12.9 Spain Market Size and Forecast, by Process
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Technology
      • 16.3.13.4 Italy Market Size and Forecast, by Application
      • 16.3.13.5 Italy Market Size and Forecast, by End User
      • 16.3.13.6 Italy Market Size and Forecast, by Stage
      • 16.3.13.7 Italy Market Size and Forecast, by Device
      • 16.3.13.8 Italy Market Size and Forecast, by Solutions
      • 16.3.13.9 Italy Market Size and Forecast, by Process
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.4 Netherlands Market Size and Forecast, by Application
      • 16.3.14.5 Netherlands Market Size and Forecast, by End User
      • 16.3.14.6 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.7 Netherlands Market Size and Forecast, by Device
      • 16.3.14.8 Netherlands Market Size and Forecast, by Solutions
      • 16.3.14.9 Netherlands Market Size and Forecast, by Process
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Technology
      • 16.3.15.4 Sweden Market Size and Forecast, by Application
      • 16.3.15.5 Sweden Market Size and Forecast, by End User
      • 16.3.15.6 Sweden Market Size and Forecast, by Stage
      • 16.3.15.7 Sweden Market Size and Forecast, by Device
      • 16.3.15.8 Sweden Market Size and Forecast, by Solutions
      • 16.3.15.9 Sweden Market Size and Forecast, by Process
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.4 Switzerland Market Size and Forecast, by Application
      • 16.3.16.5 Switzerland Market Size and Forecast, by End User
      • 16.3.16.6 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.7 Switzerland Market Size and Forecast, by Device
      • 16.3.16.8 Switzerland Market Size and Forecast, by Solutions
      • 16.3.16.9 Switzerland Market Size and Forecast, by Process
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Technology
      • 16.3.17.4 Denmark Market Size and Forecast, by Application
      • 16.3.17.5 Denmark Market Size and Forecast, by End User
      • 16.3.17.6 Denmark Market Size and Forecast, by Stage
      • 16.3.17.7 Denmark Market Size and Forecast, by Device
      • 16.3.17.8 Denmark Market Size and Forecast, by Solutions
      • 16.3.17.9 Denmark Market Size and Forecast, by Process
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Technology
      • 16.3.18.4 Finland Market Size and Forecast, by Application
      • 16.3.18.5 Finland Market Size and Forecast, by End User
      • 16.3.18.6 Finland Market Size and Forecast, by Stage
      • 16.3.18.7 Finland Market Size and Forecast, by Device
      • 16.3.18.8 Finland Market Size and Forecast, by Solutions
      • 16.3.18.9 Finland Market Size and Forecast, by Process
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Technology
      • 16.3.19.4 Russia Market Size and Forecast, by Application
      • 16.3.19.5 Russia Market Size and Forecast, by End User
      • 16.3.19.6 Russia Market Size and Forecast, by Stage
      • 16.3.19.7 Russia Market Size and Forecast, by Device
      • 16.3.19.8 Russia Market Size and Forecast, by Solutions
      • 16.3.19.9 Russia Market Size and Forecast, by Process
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Solutions
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Solutions
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Technology
      • 16.4.9.4 China Market Size and Forecast, by Application
      • 16.4.9.5 China Market Size and Forecast, by End User
      • 16.4.9.6 China Market Size and Forecast, by Stage
      • 16.4.9.7 China Market Size and Forecast, by Device
      • 16.4.9.8 China Market Size and Forecast, by Solutions
      • 16.4.9.9 China Market Size and Forecast, by Process
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Technology
      • 16.4.10.4 India Market Size and Forecast, by Application
      • 16.4.10.5 India Market Size and Forecast, by End User
      • 16.4.10.6 India Market Size and Forecast, by Stage
      • 16.4.10.7 India Market Size and Forecast, by Device
      • 16.4.10.8 India Market Size and Forecast, by Solutions
      • 16.4.10.9 India Market Size and Forecast, by Process
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Technology
      • 16.4.11.4 Japan Market Size and Forecast, by Application
      • 16.4.11.5 Japan Market Size and Forecast, by End User
      • 16.4.11.6 Japan Market Size and Forecast, by Stage
      • 16.4.11.7 Japan Market Size and Forecast, by Device
      • 16.4.11.8 Japan Market Size and Forecast, by Solutions
      • 16.4.11.9 Japan Market Size and Forecast, by Process
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Technology
      • 16.4.12.4 South Korea Market Size and Forecast, by Application
      • 16.4.12.5 South Korea Market Size and Forecast, by End User
      • 16.4.12.6 South Korea Market Size and Forecast, by Stage
      • 16.4.12.7 South Korea Market Size and Forecast, by Device
      • 16.4.12.8 South Korea Market Size and Forecast, by Solutions
      • 16.4.12.9 South Korea Market Size and Forecast, by Process
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Technology
      • 16.4.13.4 Australia Market Size and Forecast, by Application
      • 16.4.13.5 Australia Market Size and Forecast, by End User
      • 16.4.13.6 Australia Market Size and Forecast, by Stage
      • 16.4.13.7 Australia Market Size and Forecast, by Device
      • 16.4.13.8 Australia Market Size and Forecast, by Solutions
      • 16.4.13.9 Australia Market Size and Forecast, by Process
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Technology
      • 16.4.14.4 Singapore Market Size and Forecast, by Application
      • 16.4.14.5 Singapore Market Size and Forecast, by End User
      • 16.4.14.6 Singapore Market Size and Forecast, by Stage
      • 16.4.14.7 Singapore Market Size and Forecast, by Device
      • 16.4.14.8 Singapore Market Size and Forecast, by Solutions
      • 16.4.14.9 Singapore Market Size and Forecast, by Process
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.4 Indonesia Market Size and Forecast, by Application
      • 16.4.15.5 Indonesia Market Size and Forecast, by End User
      • 16.4.15.6 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.7 Indonesia Market Size and Forecast, by Device
      • 16.4.15.8 Indonesia Market Size and Forecast, by Solutions
      • 16.4.15.9 Indonesia Market Size and Forecast, by Process
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.4 Taiwan Market Size and Forecast, by Application
      • 16.4.16.5 Taiwan Market Size and Forecast, by End User
      • 16.4.16.6 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.7 Taiwan Market Size and Forecast, by Device
      • 16.4.16.8 Taiwan Market Size and Forecast, by Solutions
      • 16.4.16.9 Taiwan Market Size and Forecast, by Process
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.4 Malaysia Market Size and Forecast, by Application
      • 16.4.17.5 Malaysia Market Size and Forecast, by End User
      • 16.4.17.6 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.7 Malaysia Market Size and Forecast, by Device
      • 16.4.17.8 Malaysia Market Size and Forecast, by Solutions
      • 16.4.17.9 Malaysia Market Size and Forecast, by Process
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Technology
    • 16.5.5 Latin America Market Size and Forecast, by Application
    • 16.5.6 Latin America Market Size and Forecast, by End User
    • 16.5.7 Latin America Market Size and Forecast, by Stage
    • 16.5.8 Latin America Market Size and Forecast, by Device
    • 16.5.9 Latin America Market Size and Forecast, by Solutions
    • 16.5.10 Latin America Market Size and Forecast, by Process
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Technology
      • 16.5.9.4 Brazil Market Size and Forecast, by Application
      • 16.5.9.5 Brazil Market Size and Forecast, by End User
      • 16.5.9.6 Brazil Market Size and Forecast, by Stage
      • 16.5.9.7 Brazil Market Size and Forecast, by Device
      • 16.5.9.8 Brazil Market Size and Forecast, by Solutions
      • 16.5.9.9 Brazil Market Size and Forecast, by Process
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Technology
      • 16.5.10.4 Mexico Market Size and Forecast, by Application
      • 16.5.10.5 Mexico Market Size and Forecast, by End User
      • 16.5.10.6 Mexico Market Size and Forecast, by Stage
      • 16.5.10.7 Mexico Market Size and Forecast, by Device
      • 16.5.10.8 Mexico Market Size and Forecast, by Solutions
      • 16.5.10.9 Mexico Market Size and Forecast, by Process
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Technology
      • 16.5.11.4 Argentina Market Size and Forecast, by Application
      • 16.5.11.5 Argentina Market Size and Forecast, by End User
      • 16.5.11.6 Argentina Market Size and Forecast, by Stage
      • 16.5.11.7 Argentina Market Size and Forecast, by Device
      • 16.5.11.8 Argentina Market Size and Forecast, by Solutions
      • 16.5.11.9 Argentina Market Size and Forecast, by Process
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Solutions
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Solutions
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Solutions
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Technology
      • 16.6.10.4 UAE Market Size and Forecast, by Application
      • 16.6.10.5 UAE Market Size and Forecast, by End User
      • 16.6.10.6 UAE Market Size and Forecast, by Stage
      • 16.6.10.7 UAE Market Size and Forecast, by Device
      • 16.6.10.8 UAE Market Size and Forecast, by Solutions
      • 16.6.10.9 UAE Market Size and Forecast, by Process
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Technology
      • 16.6.11.4 South Africa Market Size and Forecast, by Application
      • 16.6.11.5 South Africa Market Size and Forecast, by End User
      • 16.6.11.6 South Africa Market Size and Forecast, by Stage
      • 16.6.11.7 South Africa Market Size and Forecast, by Device
      • 16.6.11.8 South Africa Market Size and Forecast, by Solutions
      • 16.6.11.9 South Africa Market Size and Forecast, by Process
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Solutions
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 BeiGene
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Innovent Biologics
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Zai Lab
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Hutchmed
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Array BioPharma
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Blueprint Medicines
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Mirati Therapeutics
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Turning Point Therapeutics
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Iovance Biotherapeutics
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 MacroGenics
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Daiichi Sankyo
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Eisai
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Sumitomo Dainippon Pharma
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Chugai Pharmaceutical
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Kyowa Kirin
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis